“Bump and grind”: An exploratory study of Mephedrone users' perceptions of sexuality and sexual risk

Drugs and Alcohol Today

Volumn 11, Issue 2, 2011, Pages 93-103

  Claire Van Hout, Marie ^a   Brennan, Rebekah ^b  

^a South East Technological University   (Ireland)

^b Addiction Training Institute   (Ireland)

Author keywords

Drugs; Mephedrone; Risk environments; Sexual behaviour; Substitute cathinones

Indexed keywords

EID: 84857841114     PISSN: 17459265     EISSN: None     Source Type: Journal    
DOI: 10.1108/17459261111174046     Document Type: Article

References (59)

1. Archer, R.P. (2009), “Fluoromethcathinone, a new substance of abuse”, Forensic Science International, Vol. 185, pp. 10–20.
2. Bailey, S.L., Gao, W. and Clark, D.B. (2006), “Diary study of substance use and unsafe sex among adolescents with substance use disorders”, Journal of Adolescent Health, Vol. 38, p. 297.
3. Bellis, M.A. and Hughes, K. (2004), “Sex potions: relationships between alcohol, drugs and sex”, Adicciones, Vol. 16, pp. 251–60.
4. Bellis, M.A., Hughes, K., Calafat, A., Juan, M., Ramon, A., Rodriguez, J.A., Mendes, F., Schnitzer, S. and Phillips-Howard, P. (2008), “Sexual uses of alcohol and drugs and the associated health risks: a cross sectional study of young people in nine European cities”, BMC Public Health, Vol. 8, pp. 155–66.
5. Brandt, S.D., Sumnall, H.R., Measham, F. and Cole, J. (2010), “Analyses of second-generation ‘legal highs’ in the UK: Initial findings”, Drug Testing and Analysis, Vol. 2, pp. 377–82.
6. Brunt, T.M., Poortman, A., Niesink, R.J. and van den Brink, W. (2010), “Instability of the ecstasy market and a new kid on the block: mephedrone”, Journal of Psychopharmacology, September 8 (in press).
7. Calafat, A., Fernandez, C., Juan, M., Anttila, A., Arias, R., Bellis, M.A., Bohrn, K., Fenk, R., Hughes, K., Kerschl, A.V., Kokkevi, A., Kuussaari, K., Leenders, F., Mendes, F., Simon, J., Spyropoulou, M., van de Wijngaart, G. and Zavatti, P. (2003), Enjoying the Nightlife in Europe: The Role of Moderation, IREFREA, Valencia.
8. Dargan, P.I. and Wood, D. (2010), “Novel and emerging recreational drugs”, Toxicology Letters, Vol. 196S, pp. S1-S36.
9. Dargan, P.I., Albert, S. and Wood, D.M. (2010), “Mephedrone use and associated adverse effects in school and college/university students before the UK legislation change”, QJM, Vol. 103, pp. 875–9.
10. Davies, S., Button, J., Archer, R., Ransay, J. and Holt, D. (2010), Methcathinone derivatives: Findings from Test Purchases of Capsules and Powders from the Internet, Kingston University, Surrey.
11. de Visser, R. and Smith, A. (2001), “Relationship between Sexual partners influences rates and correlates of condom use”, AIDS Education and Prevention, Vol. 13, pp. 413–27.
12. Deehan, A. and Saville, E. (2003), Calculating the Risk: Recreational Drug Use among Clubbers in the South East of England, Home Office, London.
13. Deluca, P., Schifano, F., Davey, Z., Corazza, O., Di Furia, L. and the Psychonaut Web Mapping Research Group (2009), Mephedrone Report. Institute of Psychiatry, King's College of London, London, available at: www.psychonautproject.eu (accessed 11 September 2010).
14. Dickson, A.J., Vorce, S.P. Levine, B. and Past, M.R. (2010), “Multiple-drug toxicity caused by the coadministration of 4-methylmethcathinone (mephedrone) and heroin”, Journal of Analytical Toxicology, Vol. 34 No. 3, pp. 162–8.
15. Drumright, L.N., Patterson, T.L. and Strathdee, S. (2006), “Club drugs as causal risk factors for HIV acquisition among men who have sex with men: a review”, Substance Use and Misuse, Vol. 41, pp. 1551–601.
16. EMCDDA (2010), “Europol-EMCDDA joint report on a new psychoactive substance: 4-methylmethcathinone (mephedrone)”, available at: www.emcdda.europa.eu/drug-situation/new-drugs (accessed 28 May 2010).
17. Friedman, S.R., Mateu-Gelabert, P. and Sandoval, M. (2010), “Review Group sex events amongst non-gay drug users: an understudied risk environment”, International Journal of Drug Policy, Vol. 22 No. 1, pp. 1–8.
18. Frohmader, K.S., Pitchers, K.L., Balfour, M. and Coolen, L.M. (2010), “Mixing pleasures: review of the effects of drugs on sex behavior in humans and animal models”, Hormones and Behavior, Vol. 58, pp. 149–62.
19. Gibbons, S. and Zloh, M. (2010), “An analysis of the ‘legal high’ mephedrone”, Bioorganic and Medicinal Chemistry Letters, Vol. 20, pp. 4135–9.
20. Green, A.I. and Halkitis, P.N. (2006), “Crystal methamphetamine and sexual sociality in an urban gay subculture: an elective affinity”, Culture Health and Sex, Vol. 8, pp. 317–33.
21. Hillebrand, J., Olszewski, D. and Sedefov, R. (2010), “Legal highs on the internet”, Substance Use and Misuse, Vol. 45, pp. 330–40.
22. Klitzman, R., Greenberg, J.D., Pollack, L.M. and Dolezal, C. (2002), “MDMA (‘ecstasy’) use, and its association with high risk behaviors, mental health, and other factors among gay/bisexual men in New York City”, Drug and Alcohol Dependence, Vol. 66, pp. 115–25.
23. Krauss, B.J., O'Day, J., Godfrey, C., Rente, K., Freidin, E. and Bratt, E. (2006), “Who wins in the status games? Violence, sexual violence, and an emerging single standard among adolescent women”, Annals of the New York Academy of Sciences, Vol. 1087, pp. 56–73.
24. Lewis, L. and Ross, M. (1995), A Select Body: The Gay Dance Party Subculture and the HIV/AIDS Pandemic, Cassell, London.
25. McElrath, K. (2005), “Ecstasy users' perceptions about sexuality and sexual risk”, Substance Use and Misuse, Vol. 40, pp. 1461–77.
26. McElrath, K. and O'Neill, C. (2011), “Experiences with mephedrone pre- and post-legislative controls: perceptions of safety and sources of supply”, International Journal of Drug Policy, Vol. 22 No. 2, pp. 120–7.
27. McElrath, K. and van Hout, MC (2011), “A preference for mephedrone: drug markets, drugs of choice and the emerging ‘legal high’ scene”, Journal of Drug Issues (in press).
28. Mattison, A.M., Ross, M.W., Wolfson, T., Franklin, D. and HNRC Group (2001), “Circuit party attendance, club drug use, and unsafe sex in gay men”, Journal of Substance Abuse, Vol. 13, pp. 119–26.
29. Measham, F., Moore, K., Newcombe, R. and Welch, Z. (2010), “Tweaking, bombing, dabbing and stockpiling: the emergence of mephedrone and the perversity of prohibition”, Drugs and Alcohol Today, Vol. 10 No. 1, pp. 14–21.
30. Mephedrone2you (2010), available at: www.mephedrone2u.com/ (accessed 10 September 2010).
31. Mishler, E. (1986), Research Interviewing: Context and Narrative, Harvard University Press, Cambridge, MA.
32. Mitcheson, L., McCambridge, J., Byrne, A., Hunt, N. and Winstock, A. (2008), “Sexual health risk among dance drug users: cross-sectional comparisons with nationally representative data”, Journal of Drug Policy, Vol. 19, pp. 304–10.
33. MixMag (2010), “The mixmag drug survey”, Mephedrone: Meet the UK's Favourite New Drug, February, pp. 44–53, available at: www.mixmag.net/mephedrone (accessed 10 April 2010).
34. Morgan, P. and Beck, J. (1997), “The legacy and the paradox: hidden contexts of methamphetamine use in the United States”, in Klee, H. (Ed.), Amphetamine Misuse: International Perspectives on Current Trends, Harwood Academic Publishers, The Netherlands, pp. 135–79.
35. Morris, K. (2010), “UK places generic ban on mephedrone drug family”, The Lancet, Vol. 375 No. 17, pp. 1333–4.
36. Newcombe, R. (2009), Mephedrone: The Use of Mephedrone (m-cat, meow) in Middlesbrough, Lifeline Publications and Research, Manchester, pp. 1–16.
37. Ostrow, D.G. (2000), “The role of drugs in the sexual lives of men who have sex with men: continuing barriers to researching this question”, AIDS and Behavior, Vol. 4, pp. 205–19.
38. Passie, T., Hartmann, U., Schneider, U., Emrich, H.M. and Tillmann Kruger, K. (2005), “Ecstasy (MDMA) mimics the post-orgasmic state: impairment of sexual drive and function during acute MDMA-effects may be due to increased prolactin secretion”, Medical Hypotheses, Vol. 64, pp. 899–903.
39. Peugh, J. and Belenko, S. (2001), “Alcohol, drugs and sexual function: a review”, Journal of Psychoactive Drugs, Vol. 33, pp. 223–32.
40. Pfaus, J.G. (2009), “Pathways of sexual desire”, Journals of Sexual Medicine, Vol. 6, pp. 1506–33.
41. Raj, A., Saitz, R., Cheng, D.M., Winter, M. and Samet, J.H. (2007), “Associations between alcohol, heroin, and cocaine use and high risk sexual behaviors among detoxification patients”, American Journal of Drug and Alcohol Abuse, Vol. 33, pp. 169–78.
42. Rawson, R.A., Washton, A., Domier, C.P. and Reiber, C. (2002), “Drugs and sexual effects: role of drug type and gender”, Journal of Substance Abuse Treatment, Vol. 22, pp. 103–8.
43. Rhodes, T. and Quirk, A. (1998), “Drug users' sexual relationships and the social organization of risk: the sexual relationship as a site of risk management”, Social Science & Medicine, Vol. 46 No. 2, pp. 157–69.
44. Rhodes, T., Millson, M., Bueno, R., Myers, T., Hunter, G.M. and Stimson, G. (1998), “Differences in sexual behaviour and condom use among cocaine and opioid injectors in Santos, Toronto and London”, International Journal of Drug Policy, Vol. 9, pp. 449–60.
45. Sammler, E.M., Foley, P.L., Lauder, G.L., Wilson, S.L., Goudie, A.R. and O'Riordan, J. (2010), “A harmless high?”, Lancet, Vol. 376, p. 742.
46. Schifano, F., Albanese, A., Fergus, S., Stair, J.L., Deluca, P., Corazza, O., Davey, Z., Corkery, J., Siemann, H., Scherbaum, N., Farre', M., Torrens, M., Demetrovics, Z., Ghodse, A.H. and Psychonaut Web Mapping & ReDNet Research Groups (2011), “Mephedrone (4-methylmethcathione: ‘meow meow’: chemical pharmacological and clinical issues”, Psychopharmacology, Vol. 214, pp. 593–602.
47. Schmidt, M.M., Sharma, A., Schifano, F. and Feinmann, C. (2011), “‘Legal highs’ on the net – evaluation of UK-based websites, products and product information”, Forensic Science International, Vol. 206 Nos 1-3, pp. 92–7.
48. Scott-Ham, M. and Burton, F. (2005), “Toxicological findings in cases of alleged drug-facilitated sexual assault in the United Kingdom over a 3-year period”, Journal of Clinical and Forensic Medicine, Vol. 12, pp. 175–86.
49. Semple, S.J., Patterson, T.L. and Grant, I. (2002), “Motivations associated with methamphetamine use among HIV men who have sex with men”, Journal of Substance. Abuse Treatment, Vol. 22, pp. 149–56.
50. Semple, S.J., Strathdee, S.A., Zians, J. and Patterson, T. (2009), “Sexual risk behavior associated with co-administration of methamphetamine and other drugs in a sample of HIV-positive men who have sex with men”, American Journal of Addiction, Vol. 18, pp. 65–72.
51. Semple, S.J., Strathdee, S.A., Zians, J. and Patterson, T.L. (2010), “Factors associated with sex in the context of methamphetamine use in different sexual venues among HIV-positive men who have sex with men”, BMC Public Health, Vol. 10, p. 178.
52. Springer, A., Peters, R., Shegog, R., White, D. and Kelder, S. (2007), “Methamphetamine use and sexual risk behaviors in US high school students: findings from a national risk behavior survey”, Prevention Science, Vol. 8, pp. 103–13.
53. Taylor, S.J. and Bogdan, R. (1984), Introduction to Qualitative Research Methods: The Search for Meanings, Wiley, New York, NY, p. 131.
54. van Hout, M.C. and Brennan, R. (2011), “Plantfood for thought: a qualitative study of mephedrone use in Ireland”, Drugs Education Prevention and Policy, Vol. 18 No. 5, pp. 371–81.
55. Vardakou, I., Pistos, C. and Spiliopoulou, C. (2011), “Drugs for youth via the internet and the example of mephedrone”, Toxicology Letters, Vol. 201, pp. 191–5.
56. Washton, A.M. and Zweben, J.E. (2009), From: Cocaine and Methamphetamine Addiction: Treatment, Recovery, and Relapse Prevention, Chapter 3, Stimulant Drugs and Sex, Norton Professional Books, New York, NY.
57. Winstock, A.R., Mitcheson, L.R., Deluca, P., Davey, Z., Corazza, O. and Schifano, F. (2011), “Mephedrone, new kid for the chop?”, Addiction, Vol. 106, pp. 154–61.
58. Zemishlany, Z., Aizenberg, D. and Weizman, A. (2001), “Subjective effects of MDMA (‘ecstasy’) on human sexual function”, European Psychiatry, Vol. 16, pp. 127–30.
59. Zule, W.A. and Desmond, D.P. (1999), “An ethnographic comparison of HIV risk behaviors among heroin and methamphetamine injectors”, American Journal of Drug and Alcohol Abuse, Vol. 25, pp. 1–23.